Skip to content

Centre- Versus Home-based Exercise for MCI and Early Dementia

How do we Get People With MCI and Dementia to be Physically Active?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02774720
Acronym
CHIME
Enrollment
44
Registered
2016-05-17
Start date
2016-09-30
Completion date
2019-03-31
Last updated
2019-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Mild Cognitive Impairment

Brief summary

The study is a proof-of-concept, double-blinded randomized, parallel group trial to compare the effectiveness of centre-based and home-based physical activity in helping people with MCI and early dementia meet physical activity recommendations. The primary outcome is achievement of physical activity recommendations. Secondary outcomes include cost-effectiveness and improvements in health and function.

Detailed description

The aim of this trial is to compare the effectiveness of center-based versus home-based physical activity delivery among people with MCI and early dementia and to understand the influence of person and setting characteristics. OBJECTIVES: Primary: To compare the effectiveness of centre-based versus home-based physical activity delivery among people with MCI or early dementia, as measured by percent achievement of physical activity guidelines. Secondary: (i) To determine the influence of person- and setting-specific factors. (ii) To estimate the cost-effectiveness of centre-based and home-based physical activity. Exploratory: i) To compare the effect of centre- and home-based physical activity on other outcomes. ii) To explore whether participants consider certain aspects of the program to be important to program effectiveness. METHODS: The investigators will conduct a 3-month proof-of-concept, double-blinded randomized, parallel group trial to compare the effectiveness of centre-based and home-based physical activity in helping people with MCI and early dementia meet physical activity recommendations. Participants will be randomized to one of two physical activity delivery options.The goal of both arms will be to have participants reach physical activity guidelines by the end of the 3-month intervention. Participants who are randomized to centre-based physical activity will attend physical activity programming at a centre (University of Waterloo or Toronto Rehabilitation Institute) once per week for one hour. Additional physical activity will be prescribed at home. Participants who are randomized to the home-based physical activity will received a physical activity prescription to be completed at home. They will also receive monthly support calls to assess achievements and barriers and to adjust the prescription. All assessors will be blinded to group allocation.

Interventions

BEHAVIORALCentre-based exercise

Participants will come to a centre (University of Waterloo or Toronto Rehabilitation Institute) for a one-hour, small group exercise class each week. The classes will include progressive aerobic and resistance exercise. They will be prescribed additional exercise to be performed independently (either at home or in the community).

BEHAVIORALHome-based exercise

Participants will be prescribed aerobic and resistance exercise to be performed independently (either at home or in the community). They will receive monthly phone calls to discuss achievements and barriers and to tje adjust exercise prescription.

Sponsors

Alzheimer's Association
CollaboratorOTHER
University of Waterloo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of MCI or mild dementia * Mini-Mental State Examination (MMSE)\>=23 or Montreal Cognitive Assessment (MoCA)\>=18 * 50 years or older * Stable pharmaceutical regimen \>=2 months * Be able to travel to centre * Have a care partner or significant other to support home-based exercise * Ability to walk \>=2 minutes * Adequate English to understand exercise training * Adequate hearing and vision for cognitive tests * Able to comply with assessment and training schedule * Be screened safe for exercise by a physician or certified exercise physiologist

Exclusion criteria

* Current moderate or high intensity exercise \>=3 times per week * Unstable cardiovascular disease that precludes exercise * Musculoskeletal impairments that limit ability to walk * Pain or other co-morbidities that would limit exercise * Behavioural issues that would limit exercise training

Design outcomes

Primary

MeasureTime frameDescription
Achievement of Physical Activity3 monthsPercent achievement of physical activity recommendations (150min/wk of moderate or high intensity physical activity) as objectively measured using an activity monitor.
Change in physical activitybaseline to 3 monthsChange in physical activity as objectively measured using an activity monitor.

Secondary

MeasureTime frameDescription
Cost-effectiveness3 monthsCost of resource utilization per minute change in physical activity.

Other

MeasureTime frameDescription
Change in blood pressurebaseline to 3 monthsChange in number with high blood pressure (\>140 systolic blood pressure (SBP), \>90 diastolic blood pressure (DBP))
Change in cognitive function as characterized by Alzheimer's Disease Assessment Scale - Cognition (ADAS-Cog)baseline to 3 monthsChange in continuous scores
Change in cognitive function as characterized by the Stroop taskbaseline to 3 monthsChange in continuous scores
Change in cognitive function as characterized by the Trail making taskbaseline to 3 monthsChange in continuous scores
Change in daily function as characterized using the 6-item Disability Assessment for Dementia (DAD-6)baseline to 3 monthsChange in score
Change in physical function as characterized by the Short Physical Performance Battery (SPPB) scoresbaseline to 3 monthsChange in continuous scores
Change in quality of life as measured with the EuroQol five dimensions questionnaire (EQ-5D)baseline to 3 monthsChange in continuous scores
Change in mood as measured with the Neuropsychiatric Inventory Questionnaire (NPI-Q) (depression/dysphoria, anxiety, apathy/indifference scales)baseline to 3 monthsChange in scores, number meeting screening criteria for depression
Change in cognitive function as characterized by the semantic fluencybaseline to 3 monthsChange in continuous scores
Change in body mass index (BMI)baseline to 3 monthsChange in score
Change in waist circumferencebaseline to 3 monthsChange in score

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026